Andere Sprachen Summit Therapeutics Inc.

Aktien

A2QDFS

US86627T1088

SMMT

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 11.07.2025			% 5 Tage	% 1. Jan.
25,00 ^USD	-3,40 %		+1,83 %	+40,10 %

04.07.	AstraZeneca und Summit Therapeutics verhandeln über mögliche 15-Milliarden-Dollar-Partnerschaft bei Lungenkrebsmittel	MT
03.07.	Astrazeneca vor Milliarden-Partnerschaft mit Summit - Agentur	DJ

Andere Sprachen

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT	12.07.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT	07.07.
Global markets live: Boeing, Tesla, Nvidia, Stellantis, Commerzbank…	04.07.
UK Stocks-Factors to watch on July 4	04.07.
Les valeurs à suivre à Paris et en Europe (actualisé)	04.07.
AstraZeneca, Summit in Talks for Potential $15 Billion Partnership on Lung-cancer Drug	04.07.
Sector Update: Health Care Stocks Mixed Thursday Afternoon	03.07.
Sector Update: Health Care	03.07.
AstraZeneca Discusses $15 Billion Partnership With Summit Therapeutics, Bloomberg Says, Citing Sources	03.07.
Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports	03.07.
Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports	03.07.
Top Midday Stories: June Jobs Report Tops Expectations; Olo to be Acquired by Thoma Bravo for $10.25 Per Share	03.07.
Astrazeneca Said in Talks With Summit on $15 Billion Partnership	03.07.
AstraZeneca Said In Talks With Summit to License Lung Cancer Drug in $15 Billion Deal, Bloomberg Reports	03.07.
Astrazeneca Said in Talks With Summit on $15 Billion Partnership	03.07.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT	02.07.
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Midcap Growth Index	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 2000 Dynamic Index	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 2000 Growth Index	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 2000 Index	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 1000 Dynamic Index	30.06.
Revolution Medicines, Summit Therapeutics Partner to Test Cancer Treatment Combinations	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 3000E Value Index	30.06.
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 2000 Value Index	30.06.
Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors	30.06.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Summit Therapeutics Inc.

Aktien

A2QDFS

US86627T1088

SMMT

Biotechnologie

Andere Sprachen

Filter